Kalaburagi district gets 1,200 vials of Remdevisir

May 11, 2021 07:16 pm | Updated 07:16 pm IST - KALABURAGI

Kalaburagi district received 1,200 more vials of Remdesivir for treating COVID-19 patients admitted to government and private hospitals across the district.

Minister for Mines and Geology Murugesh Nirani, who is also district in-charge, has, on his own initiative, procured the 1,200 vials which were flown to Kalaburagi from Bengaluru on Tuesday.

Government and private hospitals in the district are being provided with the required Remdevisir injections for administering the drug to those prescribed, he said.

Though the number of vials procured for Kalaburagi district is lower than the daily requirement, the district administration will make time to time requisition to procure more vials.

Oxygen plant

As the district is facing shortage of oxygen, it will soon get a 400-cylinder-capacity oxygen manufacturing plant. The plant will be established in Kalaburagi city in collaboration with Defence Research and Development Organisation (DRDO) and the National Highways Authority of India (NHAI).

Mr. Nirani, who held a discussion with the officials of the DRDO and NHAI, has promised to set up the oxygen manufacturing plant in the next 10 days.

Control room

To address the difficulties being faced by people in getting essential commodities during the lockdown, the Kalaburagi district administration has set up a control room to monitor the supply of such goods.

The control room will function 24 x 7 and officials from the Food and Civil Supplies Department will monitor the real-time status of transportation and delivery of goods, manufacturing and delivery of essential commodities.

The move comes in the wake of complaints to Mr. Nirani that the district authorities and police were stopping staff of e-commerce and other grocery retailers, thereby hindering supplies.

Meanwhile, officials from various departments were assigned to the control room on shift basis.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.